Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

9.19
Delayed Data
As of Jul 02
 +0.39 / +4.43%
Today’s Change
5.33
Today|||52-Week Range
15.21
+57.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$148.3M

Company Description

Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company. It is engaged in developing and manufacturing new pharmaceutical products that are used in central nervous system drugs in large and growing markets. It products include TNX-102 SL and TNX-201. Tonix Pharmaceuticals Holding was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.

Contact Information

Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue
New York New York 10022
P:(212) 980-9155
Investor Relations:

Employees

Shareholders

Mutual fund holders5.56%
Individual stakeholders5.24%
Other institutional38.34%

Top Executives

Seth LedermanChairman, President & Chief Executive Officer
Leland J. GershellChief Financial Officer & Treasurer
Gregory M. SullivanChief Medical Officer
Bruce L. DaughertySecretary, Chief Scientific Officer & Controller
Jessica E. EdgarSenior Vice President-Finance

To view my watchlist

Not a member yet?

Sign up now for a free account